Research and Development

Showing 15 posts of 9573 posts found.

amgen_hq

Amgen and Immatics enter $1bn immuno-oncology partnership

January 9, 2017 Research and Development, Sales and Marketing Amgen, immatics, immunotherapy

Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …
erik_digman_wiklund

Targovax promotes new CFO

January 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targovax

Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …

Pfizer announce positive results for Humira biosimilar

January 6, 2017 Medical Communications, Research and Development, Sales and Marketing Humira, Pfizer, biosimilar

Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …
novartis_window

Novartis and Ionis enter $1bn cardiovascular drug deal

January 6, 2017 Medical Communications, Research and Development, Sales and Marketing Akcea, Akcea Therapeutics, Ionis, Ionis Pharmaceuticals, cardiovascular

Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …
pregnancy

Morning sickness pill scientific backing called into question

January 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diclectin, Diclegis, Duchesnay, FDA, kim kardashian, morning sickness

Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …
sheep

FDA steps up fight against superbugs with livestock ruling

January 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …
inotek_logo

Inotek’s glaucoma lead candidate falls at Phase 3 trial

January 4, 2017 Research and Development Glaucoma, inotek, inotek pharma

Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …
sun_pharma

Blast at Sun Pharma factory kills two

January 4, 2017 Medical Communications, Research and Development Sun Pharma, factory, fire

A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …
amgen_hq

Amgen’s patent win upheld against Sanofi-Regeneron

January 4, 2017 Medical Communications, Research and Development Amgen, Regeneron, Sanofi, patent

In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …
texas-star

Texas launches lawsuit against FDA over lethal drug shipment

January 4, 2017 Medical Communications, Research and Development FDA, texas

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …
novartis_window

Greek authorities raid Novartis’ offices after bribery allegations

January 4, 2017 Medical Communications, Research and Development Greece, Greek, Novartis, bribery

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …
syringe

Sanofi and MSD end their joint vaccines partnership

January 3, 2017 Research and Development MSD, Sanofi, Sanofi pasteur msd

With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …
giovanni_caforio

Giovanni Caforio to be made chairman of the board at BMS

January 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …
The Gateway to Local Adoption Series

Latest content